DADC
ALDR

D.A. Davidson & Co’s Alder Biopharmaceuticals ALDR Stock Holding History

D.A. Davidson & Co’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,397
Closed -$38K – 2231
2017
Q2 		$38K Buy
3,397
+2,897
+579% +$53.6K ﹤0.01% 1626
2017
Q1 		$10K Hold
500
– – ﹤0.01% 2039
2016
Q4 		$10K Buy
+500
New +$13K ﹤0.01% 2132
2016
Q3 		– Sell
-500
Closed -$12K – 2522
2016
Q2 		$12K Hold
500
– – ﹤0.01% 1926
2016
Q1 		$12K Buy
500
+300
+150% +$6.95K ﹤0.01% 1877
2015
Q4 		$6K Sell
200
-26
-12% -$879 ﹤0.01% 2008
2015
Q3 		$7K Buy
226
+206
+1,030% +$8.76K ﹤0.01% 1958
2015
Q2 		$1K Buy
+20
New +$727 ﹤0.01% 2183

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return